The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
Abstract
The tauopathies are a group of disorders characterised by aggregation of the microtubule-associated protein tau and include Alzheimer's disease (AD) and the fronto-temporal dementias (FTD). We have used Drosophila to analyse how tau abnormalities cause neurodegeneration. By selectively co-expressing wild-type human tau (0N3R isoform) and a GFP vesicle marker in motorneurons, we examined the consequences of tau overexpression on axonal transport in vivo. The results show that overexpression of tau disrupts axonal transport causing vesicle aggregation and this is associated with loss of locomotor function. All these effects occur without neuron death. Co-expression of constitutively active glycogen-synthase kinase-3beta (GSK-3beta) enhances and two GSK-3beta inhibitors, lithium and AR-A014418, reverse both the axon transport and locomotor phenotypes, suggesting that the pathological effects of tau are phosphorylation dependent. These data show that tau abnormalities significantly disrupt neuronal function, in a phosphorylation-dependent manner, before the classical pathological hallmarks are evident and also suggest that the inhibition of GSK-3beta might have potential therapeutic benefits in tauopathies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many investigators have shown that either inhibition or genetic reduction of GSK-3β ameliorates tau-related deficits (94–99).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [94]
In the citing paper
“Drosophila models expressing human tau recapitulate key features of human tauopathies, including progressive neurodegeneration and phosphorylation at AD-related sites via conserved kinases [41, 44, 53, 59–63].”
Citations
Cites
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
A Drosophila model of Parkinson's disease
Feany, M. Β., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,156
Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939
Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820
Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Kamal, A., Almenar-Queralt, A., LeBlanc, J. F., Roberts, E. A., & Goldstein, L. S. B. (2001) · Nature · doi:10.1038/414643a · Cited by 583
Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M. K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81127-7 · Cited by 564
Kamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544
Jackson, G. R., Wiedau-Pazos, M., Sang, T.-K., Wagle, N., Brown, C. A., Massachi, S., & Geschwind, D. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00706-7 · Cited by 488
Cited by
Sorted by citations
Items 201–266 of 266
Modelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
Siney, E. J., Kurbatskaya, K., Chatterjee, S., Prasannan, P., Mudher, A. K., & Willaime‐Morawek, S. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.1 · Cited by 9
Self-citationKanaan, N. M., Himmelstein, D. S., Ward, S., Combs, B., & Binder, L. I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00056-1 · Cited by 9
P., N. N. V., Sundararajan, V., Dan, P., Venkatasubbu, G. D., & Mohideen, S. S. (2021) · Biocell · doi:10.32604/biocell.2021.015090 · Cited by 7
Neuronal Genes and Developmental Neuronal Pathways in Drosophila Life Span Control
PASYUKOVA, E. G., Symonenko, A. V., Roshina, N. V., Trostnikov, M. V., Veselkina, E. R., & Rybina, O. Y. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_1 · Cited by 8
Role of proline‐rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease
Kumar, R. K., Tiwari, V., & Dey, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15569 · Cited by 9
Iacobucci, G. J., & Gunawardena, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14230 · Cited by 7
Dysregulation of multiple signaling pathways: A possible cause of cerebral palsy
Upadhyay, J., Ansari, M. N., Samad, A., & Sayana, A. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221081022 · Cited by 7
A systematic analysis of neurobiological roles of lithium
Викторовна, Г. И., Громова, О. А., Torshin, I. Y., Гришина, Т. Р., & Пронин, А. В. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212211117 · Cited by 8
Banerjee, R., & Gunawardena, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1202307 · Cited by 7
Age dependent trans-cellular propagation of human tau aggregates in Drosophila disease models
Aqsa, A., & Sarkar, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147207 · Cited by 7
How does lithium mediate its therapeutic effects?
Strunecká, A., Patočka, J., & Šárek, M. (2005) · Journal of Applied Biomedicine · doi:10.32725/jab.2005.003 · Cited by 6
Herteleer, L., Zwarts, L., Hens, K., Forero, D. A., Del‐Favero, J., & Callaerts, P. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4223-z · Cited by 7
GSK-3 Inhibitors for the Treatment of Alzheimer's Disease
Bhat, R. V., von Berg, S., Burrows, J. N., & Lindquist, J. M. (2007) · Springer eBooks · doi:10.1007/7355_2007_015 · Cited by 7
Self-citationAtere, T. G., Arogundade, M. T., Adewale, O. O., & Idowu, O. K. (2025) · BioNanoScience · doi:10.1007/s12668-025-01938-y · Cited by 5
Drosophila GSK3β promotes microtubule disassembly and dendrite pruning in sensory neurons
Dzaki, N., Bu, S., Lau, S. S. Y., Yong, W. L., & Yu, F. (2022) · Development · doi:10.1242/dev.200844 · Cited by 5
Afolayan, O. O., Nwaogu, V., Idowu, O. K., & Dosumu, O. O. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05093-5 · Cited by 4
Pharmacological Treatment of Alzheimer’s Disease
Ballard, C. G., Sorensen, S., Aarsland, D., & Alzheimer’s Society, L. (2008) · European Neurological Review · doi:10.17925/enr.2008.03.01.23 · Cited by 4
Konsta, V., Paschou, M., Koti, N., Vlachou, M. E., Livanos, P., Xilouri, M., & Papazafiri, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111637 · Cited by 3
Baumgartner, T. J., Dvorak, N. M., Goode, N. A., Haghighijoo, Z., Marosi, M., Singh, J., Singh, A. K., & Laezza, F. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108162 · Cited by 3
Lovestone, S., & Killick, R. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_9 · Cited by 3
Self-citationExamining the vulnerability of adult neuron subtypes to tau-mediated toxicity in Drosophila
Sivanantharajah, L., Mudher, A. K., & Shepherd, D. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03342-2 · Cited by 2
Self-citationIdowu, O. K., Oremosu, A. A., & Dosumu, O. O. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106135 · Cited by 2
Drosophila Models of Tauopathy
Ali, Y., Ruan, K., & Zhai, R. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00054-8 · Cited by 2
The Neurobiological Role of Lithium Salts
Викторовна, Г. И., Громова, О. А., Torshin, I. Y., Гришина, Т. Р., & Пронин, А. В. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01485-7 · Cited by 2
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?
Lozupone, M., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Sborgia, G., Daniele, A., Solfrizzi, V., et al. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2546867 · Cited by 3
[Aphasia, prosopagnosia and mania: a case diagnosed with right temporal variant semantic dementia].
Turan, Ç., Kesebir, S., Meteris, H., & Ülker, M. (2013) · PubMed · Cited by 2
Insights into amyloid disease from fly models
Chen, K., & Crowther, D. C. (2014) · Essays in Biochemistry · doi:10.1042/bse0560069 · Cited by 2
Scarpelli, E. M., Trinh, V. Y., Tashnim, Z., Krans, J. L., Keller, L. C., & Colodner, K. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226380 · Cited by 3
Pragati, & Sarkar, S. (2021) · BioFactors · doi:10.1002/biof.1721 · Cited by 2
School Students as Drosophila Experimenters
Siyad, F., Griffiths, J., Janjua, F. K., Jackson, E. G., Rodrigues, I. A. S., Kerr, F., Mackay, D., & Lovestone, S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030246 · Cited by 2
Self-citationTau-Centric Therapies for Treating Alzheimer’s Disease
Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1
Self-citationAssi, L. A., Saleh, F., Khalil, M. I. M., & Eid, A. A. (2025) · Diabetology · doi:10.3390/diabetology6040026 · Cited by 1
Price, R., Moreno, M. R., Cooper, A. S., Singh, R., Khaw, Y. M., Mhaka, A. M., Sivanantharajah, L., & Mudher, A. K. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2498675 · Cited by 1
Self-citationKolacheva, A. A., Troshev, D. V., Antonova, A., Pavlova, E., Bogdanov, V. V., Kalashnikova, V. I., Popova, A., Shchepina, M., & Ugrumov, M. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114895 · Cited by 1
Trait, State, and Mechanism: Looking Back, Looking Forward, and Understanding Why
Lovestone, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129014 · Cited by 1
Self-citationModeling Huntington Disease in Yeast and Invertebrates
Mason, R. P., Breda, C., Kooner, G. S., Mallucci, G. R., Kyriacou, C. P., & Giorgini, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00033-0 · Cited by 2
Mighty Fly: An Introduction to Drosophila
Sharma, V., Mishra, A. K., Mutsuddi, M., & Mukherjee, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_1 · Cited by 1
Sergeant, N., & Buée, L. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_4 · Cited by 1
Neurodegeneration models in Drosophila
Roy, B., & Jackson, G. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.012 · Cited by 1
Live-Imaging of Axonal Cargoes in Drosophila Brain Explants Using Confocal Microscopy
Médioni, C., Ephrussi, A., & Besse, F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1916-2_2 · Cited by 1
Genetic analysis of Shudderer, the lithium-responsive neurological mutant of Drosophila melanogaster
Kaas, G. A. (2010) · doi:10.17077/etd.onbjj9u7 · Cited by 1
Drosophila Melanogaster as a Model Organism for Dementia
Giannakou, M. E., & Crowther, D. C. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_12 · Cited by 1
Cooper, A. S., Richardson, B., Ruiz, E., Zhang, Y., Batchelor, B., Chithran, A. V., Liu, J., Lian, T., Moreno, M. R., Boehme, B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.22.629946 · Cited by 1
Self-citationGupta, R., McGinnis, H., Rastegari, E., Price, M. S., & Venkatachalam, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.27.684860 · Cited by 1
Franco, B. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)
Regulation of the kinase MARK from Rattus norvegicus (Brekenhout, 1769) by GSK3
Balusamy, K. (2007) · Max Planck Institute for Plasma Physics
Self-Destruct Programs in the Processes of Developing Neurons
Shepherd, D., & Perry, V. H. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)65005-8
Self-citationNon‐amyloid Approaches To Alzheimer's Disease
Veng, L., Savage, M. J., Barrow, J. C., & Zerbinatti, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc253
The Rationale for Glutamatergic Therapy in Alzheimer's Disease
Francis, P. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_6
Pseudophosphorylation of tau modulates its function and induces AD-like changes
Sun, Q. (2009) · KU ScholarWorks (The University of Kansas)
Tau Pathology: A Selected View on the Current Status
Gozes, I. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_5
Baldwin, K. R. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Drosophila model of cognitive disorders: Focus on memory abnormality
Shao, L., & Zhong, Y. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.013
A Drosophila model of Alzheimer's disease
Crowther, D. C., Page, R., Chandraratna, D. S., & Lomas, D. A. (2006) · UCL Discovery (University College London)
Sinadinos, C., & Mudher, A. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_5
Self-citationIn Vivo Imaging of Axonal Transport in Aging and Alzheimer’s Disease
Cross, D. J., & Minoshima, S. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_23
Invertebrate and Vertebrate Models of Tauopathies
Götz, J., Ittner, L. M., Götz, N. N., Lam, H., & Nicholas, H. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00069
Les nanotubes comme nouvelle voie de transfert et de propagation de la protéine Tau pathologique
Tardivel, M. (2017) · theses.fr (ABES) · doi:10.70675/0cfcd049z970ez4f2dz8417z195cfabdc00d
Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
Barbereau, C. (2020) · theses.fr (ABES) · doi:10.70675/dfe1802ez70f2z4da6zb3e5z63d1de7a429c
Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
Derisbourg, M. J. (2015) · theses.fr (ABES) · doi:10.70675/ef5f45b0zf4e8z433fz9beaz8d2cc6de65bc
Nguyen, M. N., Ryu, T. H., Lee, J.-S., Hong, S.-H., Yoon, S.-E., Kim, Y.-J., & Yu, K. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120169
Parikh, I. J. (2014) · UKnowledge (University of Kentucky)
TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models
Roy, B., Contu, V. R., Jeziorek, M., Friedman, W. J., & Wong, C.-O. (2026) · doi:10.64898/2026.10.21.760809
Metadata
- Authors
- Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., Bhat, R., & Lovestone, S.
- Affiliations
- King's College London (GB)
- University of Southampton (GB)
- AstraZeneca (Sweden) (SE)
- Corresponding author
- Lovestone, S
- Venue
- Molecular Psychiatry
- Published
- 2004-03-02
- Volume
- 9
- Issue
- 5
- Pages
- 522-530
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2020815630
- Cited by
- 265
- References
- 35
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 5 · 2022: 9 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 11 · 2015: 9 · 2014: 18 · 2013: 14 · 2012: 22
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Update notices
- erratum (2004-07-26)
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurobiology and Insect Physiology Research
- Keywords
- tauopathy, glycogen synthase kinase-3β, GSK-3β inhibition, tau phosphorylation, axonal transport, vesicle aggregation, locomotor dysfunction, motor neurons, lithium, AR-A014418, Alzheimer's disease, frontotemporal dementia, neurodegeneration, Drosophila model
- MeSH terms
- Animals, Axons, Axonal Transport, Drosophila melanogaster, Enzyme Inhibitors, Humans, Larva, Locomotion, Phosphorylation, Protein Processing, Post-Translational, Recombinant Fusion Proteins, Thiazoles, Urea, tau Proteins, Lithium Chloride, Tauopathies, Drosophila Proteins, Glycogen Synthase Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review